Literature DB >> 7907957

HIV-1 infection of monocyte-derived macrophages reduces Fc and complement receptor expression.

S J Kent1, G Stent, S Sonza, S D Hunter, S M Crowe.   

Abstract

Fc receptor (FcR) and complement receptor (CR) expression on HIV-infected monocyte-derived macrophages may be an important determinant of immune function. We studied the effects of HIV-1 infection of macrophages in vitro on FcR and CR expression. Macrophages were infected with HIV-1DV 7 days following isolation, and the expression of Fc gamma RI-III and CR3 were measured at intervals thereafter by flow cytometry. We found a reduction in receptor expression with the percentage of cells expressing FcRI 14 days post infection declining from 77% to 13%, FcRII fell from 96% to 85%, FcRIII from 45% to 9%, and CR3 from 91% to 67% 14 days following infection. As these receptors are important for macrophage function, their down-modulation may contribute to the pathogenesis of HIV-related disease.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7907957      PMCID: PMC1535088          DOI: 10.1111/j.1365-2249.1994.tb07017.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  46 in total

Review 1.  Function and heterogeneity of human Fc receptors for immunoglobulin G.

Authors:  J C Unkeless
Journal:  J Clin Invest       Date:  1989-02       Impact factor: 14.808

Review 2.  Antibody-cell interactions: Fc receptors.

Authors:  J P Kinet
Journal:  Cell       Date:  1989-05-05       Impact factor: 41.582

3.  HIV-1 and its envelope glycoprotein down-regulate chemotactic ligand receptors and chemotactic function of peripheral blood monocytes.

Authors:  S M Wahl; J B Allen; S Gartner; J M Orenstein; M Popovic; D E Chenoweth; L O Arthur; W L Farrar; L M Wahl
Journal:  J Immunol       Date:  1989-05-15       Impact factor: 5.422

4.  Surface markers of monocyte function and activation in AIDS.

Authors:  B L Davidson; R L Kline; J Rowland; T C Quinn
Journal:  J Infect Dis       Date:  1988-08       Impact factor: 5.226

Review 5.  Structure and function of Fc receptors on macrophages and lymphocytes.

Authors:  I Mellman; T Koch; G Healey; W Hunziker; V Lewis; H Plutner; H Miettinen; D Vaux; K Moore; S Stuart
Journal:  J Cell Sci Suppl       Date:  1988

6.  Change in expression of Fc gamma RIII (CD16) on neutrophils from human immunodeficiency virus-infected individuals.

Authors:  P Boros; E Gardos; G J Bekesi; J C Unkeless
Journal:  Clin Immunol Immunopathol       Date:  1990-02

7.  Effect of viral infection of Fc receptors and immunologically nonspecific receptors of blood polymorphonuclear leukocytes: an in vitro model.

Authors:  M Niemiałtowski
Journal:  Acta Virol       Date:  1989-03       Impact factor: 1.162

8.  Monocyte phenotype and function in patients with the acquired immunodeficiency syndrome (AIDS) and AIDS-related disorders.

Authors:  J G Haas; G Riethmüller; H W Ziegler-Heitbrock
Journal:  Scand J Immunol       Date:  1987-10       Impact factor: 3.487

9.  Selective depletion of low-density CD8+, CD16+ lymphocytes during HIV infection.

Authors:  F Vuillier; N E Bianco; L Montagnier; G Dighiero
Journal:  AIDS Res Hum Retroviruses       Date:  1988-04       Impact factor: 2.205

10.  Role of the mononuclear phagocyte system in the immunopathogenesis of human immunodeficiency virus infection and the acquired immunodeficiency syndrome.

Authors:  B S Bender; B L Davidson; R Kline; C Brown; T C Quinn
Journal:  Rev Infect Dis       Date:  1988 Nov-Dec
View more
  6 in total

1.  Infection of primary human monocytes by Epstein-Barr virus.

Authors:  M Savard; C Bélanger; M Tardif; P Gourde; L Flamand; J Gosselin
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

2.  Modulation of the effector function of human macrophages for Histoplasma capsulatum by HIV-1. Role of the envelope glycoprotein gp120.

Authors:  S Chaturvedi; S L Newman
Journal:  J Clin Invest       Date:  1997-09-15       Impact factor: 14.808

3.  Effect of complement on HIV-2 plasma antiviral activity is intratype specific and potent.

Authors:  Gülşen Özkaya Şahin; Birgitta Holmgren; Enas Sheik-Khalil; Zacarias da Silva; Jens Nielsen; Salma Nowroozalizadeh; Fredrik Månsson; Hans Norrgren; Peter Aaby; Eva Maria Fenyö; Marianne Jansson
Journal:  J Virol       Date:  2012-10-17       Impact factor: 5.103

4.  Protective effect of vaginal application of neutralizing and nonneutralizing inhibitory antibodies against vaginal SHIV challenge in macaques.

Authors:  C Moog; N Dereuddre-Bosquet; J-L Teillaud; M E Biedma; V Holl; G Van Ham; L Heyndrickx; A Van Dorsselaer; D Katinger; B Vcelar; S Zolla-Pazner; I Mangeot; C Kelly; R J Shattock; R Le Grand
Journal:  Mucosal Immunol       Date:  2013-04-17       Impact factor: 7.313

5.  The kinetics of surface expression of CD11/CD18 integrins and CD54 on monocytes and macrophages.

Authors:  G Stent; L Irving; S Lewin; S M Crowe
Journal:  Clin Exp Immunol       Date:  1995-05       Impact factor: 4.330

Review 6.  Defective Phagocytic Properties of HIV-Infected Macrophages: How Might They Be Implicated in the Development of Invasive Salmonella Typhimurium?

Authors:  Gabrielle Lê-Bury; Florence Niedergang
Journal:  Front Immunol       Date:  2018-03-23       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.